Respiratory Synctial Virus: Clinical Trials

1 trial for Respiratory Synctial Virus, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 completed. 1 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 11Completed 1

Follow Respiratory Synctial Virus: new trials by email Literature Review of Respiratory Synctial Virus trials Research Report on Respiratory Synctial Virus

Trials (filtered) newest first · largest first

All 1 trial

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Phase I Randomized, Observer-Blinded, Dose-Ranging Study in Healthy Subjects 24 to <72 Months of Age
RSV F Vaccine with adjuvant (0.5mL injection), RSV F Vaccine (0.5mL injection), Hepatitis A Vaccine (0.5mL injection) - Respiratory Synctial Virus
Phase 1CompletedNovavax322014-11-012016-04-28

Interventions

Adjuvants, Pharmaceutic (1)  ·  Hepatitis A Vaccines (1)  ·  Injections (1)

Sponsors

Novavax (1)

Countries

Canada (1)

Top investigators

D. Nigel Thomas, Ph.D. (1)